FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214940881> ?p ?o ?g. }

• W4214940881 abstract "Abstract The respiratory tract represents the key target for antiviral delivery in early interventions to prevent severe COVID-19. While neutralizing monoclonal antibodies (mAb) possess considerable efficacy, their current reliance on parenteral dosing necessitates very large doses and places a substantial burden on the healthcare system. In contrast, direct inhaled delivery of mAb therapeutics offers the convenience of self-dosing at home, as well as much more efficient mAb delivery to the respiratory tract. Here, building on our previous discovery of Fc-mucin interactions crosslinking viruses to mucins, we showed that regdanvimab, a potent neutralizing mAb already approved for COVID-19 in several countries around the world, can effectively trap SARS-CoV-2 virus-like-particles in fresh human airway mucus. IN-006, a reformulation of Regdanvimab, was stably nebulized across a wide range of concentrations, with no loss of activity and no formation of aggregates. Finally, nebulized delivery of IN-006 resulted in 100-fold greater mAb levels in the lungs of rats compared to serum, in marked contrast to intravenously dosed mAbs. These results not only support our current efforts to evaluate the safety and efficacy of IN-006 in clinical trials, but more broadly substantiate nebulized delivery of human antiviral mAbs as a new paradigm in treating SARS-CoV-2 and other respiratory pathologies." @default.
• W4214940881 created "2022-03-05" @default.
• W4214940881 creator A5001533133 @default.
• W4214940881 creator A5009505291 @default.
• W4214940881 creator A5016783955 @default.
• W4214940881 creator A5023945864 @default.
• W4214940881 creator A5032880051 @default.
• W4214940881 creator A5039766927 @default.
• W4214940881 creator A5046013845 @default.
• W4214940881 creator A5052143055 @default.
• W4214940881 creator A5064102348 @default.
• W4214940881 creator A5066538135 @default.
• W4214940881 creator A5071846305 @default.
• W4214940881 creator A5079956311 @default.
• W4214940881 creator A5084736473 @default.
• W4214940881 creator A5087267489 @default.
• W4214940881 creator A5088203507 @default.
• W4214940881 creator A5089827081 @default.
• W4214940881 date "2022-03-01" @default.
• W4214940881 modified "2023-09-26" @default.
• W4214940881 title "Stable nebulization and muco-trapping properties of Regdanvimab/IN-006 supports its development as a potent, dose-saving inhaled therapy for COVID-19" @default.
• W4214940881 cites W1519480055 @default.
• W4214940881 cites W1581316856 @default.
• W4214940881 cites W158602015 @default.
• W4214940881 cites W1965597071 @default.
• W4214940881 cites W1974076742 @default.
• W4214940881 cites W1975627577 @default.
• W4214940881 cites W1994806657 @default.
• W4214940881 cites W1996045402 @default.
• W4214940881 cites W1996970629 @default.
• W4214940881 cites W2022132405 @default.
• W4214940881 cites W2022413616 @default.
• W4214940881 cites W2024782556 @default.
• W4214940881 cites W2031200209 @default.
• W4214940881 cites W2033554860 @default.
• W4214940881 cites W2035551749 @default.
• W4214940881 cites W2043191762 @default.
• W4214940881 cites W2043249607 @default.
• W4214940881 cites W2044932535 @default.
• W4214940881 cites W2063061036 @default.
• W4214940881 cites W2064095468 @default.
• W4214940881 cites W2066243349 @default.
• W4214940881 cites W2086708917 @default.
• W4214940881 cites W2092237993 @default.
• W4214940881 cites W2104795459 @default.
• W4214940881 cites W2106258444 @default.
• W4214940881 cites W2128049245 @default.
• W4214940881 cites W2129707656 @default.
• W4214940881 cites W2136461776 @default.
• W4214940881 cites W2139556812 @default.
• W4214940881 cites W2152329221 @default.
• W4214940881 cites W2156681554 @default.
• W4214940881 cites W2159953474 @default.
• W4214940881 cites W2413350311 @default.
• W4214940881 cites W2417997453 @default.
• W4214940881 cites W2762381981 @default.
• W4214940881 cites W2783735694 @default.
• W4214940881 cites W2799948466 @default.
• W4214940881 cites W2810988926 @default.
• W4214940881 cites W2884929327 @default.
• W4214940881 cites W3011474367 @default.
• W4214940881 cites W3015851157 @default.
• W4214940881 cites W3019768930 @default.
• W4214940881 cites W3030748957 @default.
• W4214940881 cites W3105466102 @default.
• W4214940881 cites W3110580506 @default.
• W4214940881 cites W3112792752 @default.
• W4214940881 cites W3130184808 @default.
• W4214940881 cites W3138789532 @default.
• W4214940881 cites W3153515080 @default.
• W4214940881 cites W3210342412 @default.
• W4214940881 cites W4212988737 @default.
• W4214940881 doi "https://doi.org/10.1101/2022.02.27.482162" @default.
• W4214940881 hasPublicationYear "2022" @default.
• W4214940881 type Work @default.
• W4214940881 citedByCount "2" @default.
• W4214940881 countsByYear W42149408812022 @default.
• W4214940881 countsByYear W42149408812023 @default.
• W4214940881 crossrefType "posted-content" @default.
• W4214940881 hasAuthorship W4214940881A5001533133 @default.
• W4214940881 hasAuthorship W4214940881A5009505291 @default.
• W4214940881 hasAuthorship W4214940881A5016783955 @default.
• W4214940881 hasAuthorship W4214940881A5023945864 @default.
• W4214940881 hasAuthorship W4214940881A5032880051 @default.
• W4214940881 hasAuthorship W4214940881A5039766927 @default.
• W4214940881 hasAuthorship W4214940881A5046013845 @default.
• W4214940881 hasAuthorship W4214940881A5052143055 @default.
• W4214940881 hasAuthorship W4214940881A5064102348 @default.
• W4214940881 hasAuthorship W4214940881A5066538135 @default.
• W4214940881 hasAuthorship W4214940881A5071846305 @default.
• W4214940881 hasAuthorship W4214940881A5079956311 @default.
• W4214940881 hasAuthorship W4214940881A5084736473 @default.
• W4214940881 hasAuthorship W4214940881A5087267489 @default.
• W4214940881 hasAuthorship W4214940881A5088203507 @default.
• W4214940881 hasAuthorship W4214940881A5089827081 @default.
• W4214940881 hasBestOaLocation W42149408811 @default.
• W4214940881 hasConcept C126322002 @default.
• W4214940881 hasConcept C142724271 @default.
• W4214940881 hasConcept C159047783 @default.
• W4214940881 hasConcept C159654299 @default.

• next